HONG KONG SAR - Media OutReach Newswire - 19 June 2026 - Hong Kong universities continue to excel on the international stage with five institutions ranked among the world's top 100 and, for the first time, two in the top 20 of the 2027 World University Rankings published by Quacquarelli Symonds (QS) on June 18.

A spokesman for Hong Kong's Education Bureau (EDB) said that with the Hong Kong Special Administrative Region (HKSAR) Government's full commitment to developing Hong Kong into an education hub, coupled with the support of a series of policy measures, the city's higher education system has again excelled.

Announcing the results, QS said in a press release that Hong Kong "emerges as Asia's most improved higher education system for the second consecutive year, and the second most improved globally among systems with three or more ranked universities".

The University of Hong Kong (HKU) maintained its position at 11th in the world; The Chinese University of Hong Kong (CUHK) rose 14 places to 18th; The Hong Kong University of Science and Technology rose 11 places to 33rd; and The Hong Kong Polytechnic University climbed four places to 50th, entering the world's top 50 for the first time. Also among the top 100 is City University of Hong Kong, which improved 11 places to 52nd.

In the latest Best Global Universities Rankings published by the U.S. News & World Report just days ago, multiple Hong Kong universities also demonstrated exceptional international competitiveness, with 20 subjects placing in the global top 10. Notably, CUHK, HKU, and The Education University of Hong Kong swept the global top three spots for the Best Global Universities for "Education and Educational Research", underscoring the city's prowess in cultivating talents and conducting academic research.

"These achievements fully affirm the effectiveness of the HKSAR Government's steadfast investment in education and its full support through the University Grants Committee (UGC) for institutions to continuously innovate, optimise, expand capacity, and enhance quality. The significant year-on-year rise in the overall rankings of our institutions further validates Hong Kong's strong appeal as a premier hub for international high-end talent," the EDB spokesman said.

"The stellar performance of UGC-funded universities in the international rankings is by no means accidental. On one hand, it relies on the tireless efforts of all institutions to actively recruit world-class scholars and invest in infrastructure. On the other hand, the HKSAR Government's stable resource investment, clear and supportive policy guidance, as well as the rigorous quality assurance implemented through the University Accountability Agreements, are also of paramount importance."

The Government will continue to promote the internationalisation and diversification of post-secondary education, which aims to not only enhance Hong Kong's development momentum but also make proactive contributions to the nation's development, the spokesman said.

The strength demonstrated by Hong Kong's higher education system aligns perfectly with the strategic goals set out in the National 15th Five-Year Plan to build a leading nation in education, technology, and talent.

To support the post-secondary education sector to grow bigger and stronger, the Government has raised the admission ceiling for non-local students in taught programmes at funded post-secondary institutions to 50 per cent, and increased the over-enrolment ceiling for self-financing places in funded research postgraduate programmes to 120 per cent, among other measures.

Meanwhile, the Government is promoting the "Study in Hong Kong" brand. The Task Force on Study in Hong Kong, in collaboration with major institutions, is stepping up promotion of Hong Kong's excellent academic, research, and international collaboration resources on the Chinese Mainland and overseas. It also aims to attract outstanding talent from all over the world through initiatives such as expanding the Belt and Road Scholarship.

The issuer is solely responsible for the content of this announcement.

Hashtags: #HongKong #BrandHongKong #EducationHub #University #QS

Over 70 wellness sessions across six immersive festival zones from sunrise yoga and seafront runs, to strength training, breathwork, creative workshops and recovery experiences, offering something for everyone, across all ages and abilities.

SINGAPORE - Media OutReach Newswire - 19 June 2026 - Glow Festival by Prudential returns to Sentosa this July, ushering in its most expansive and immersive edition to date. From 10-19 July 2026, the highly anticipated event is back and elevated to an entirely new level, bringing together world-class wellness instructors, global music icons Jason Derulo and Alessia Cara, and unforgettable community-driven experiences in a single, immersive celebration of movement, connection and joy.

This year marks a significant new chapter for the festival through a three-year partnership with Sentosa Development Corporation (SDC), Singapore Tourism Board (STB), Prudential Singapore ("Prudential") and Exceed Sports & Entertainment, the founder of Glow Festival. Together, they share a long-term vision to grow Glow into a defining global wellness event for Singapore, one that invites people of all ages and abilities to engage with wellbeing in ways that feel accessible, social and culturally relevant.

"Glow Festival was created to reimagine how people experience wellness, making it more social, inclusive and culturally relevant," said Martin Capstick, CEO of Exceed Sports & Entertainment and Founder of Glow Festival. "Our partnerships with Prudential, SDC and STB mark a significant step forward, allowing us to scale the festival. In 2026, this comes to life through an expanded programme, global talent and immersive formats that bring people together in new ways."

Returning as Presenting Sponsor for the third consecutive year, Prudential brings back Every Body Club at Glow Festival. Every Body Club is Prudential's partner ecosystem for health, community and wellness. This year at Glow Festival, Prudential has an experiential space that invites visitors to pick up small steps to improve their wellbeing such as healthy bites and sports accessories. Prudential customers also enjoy exclusive access to physiotherapy and chiropractic consultations.

Toni Fung, Chief Customer and Marketing Officer, Prudential Singapore, said: "We are pleased to be back as the Presenting Sponsor of Glow Festival for the third consecutive year. While health and protection remain a key part of what we do, wellbeing is becoming increasingly important and deeply personal as people live longer lives. Our partner ecosystem presented through Every Body Club offers something for everyone, whether they are starting their wellness journey, staying active and connected as they age, or pursuing fitness goals."

"Sentosa's golden beaches and abundant greenery create the perfect environment for immersive wellness and restoration. This strategic partnership brings Glow Festival to life across our island, from the dedicated Festival Grounds at Palawan Green to extended programming with our island hospitality partners. The combination of beachfront locations, coastal breezes, and tranquil spaces helps guests disconnect from daily pressures and reconnect with their wellbeing in ways that feel authentic and restorative. This is the transformative wellness experience we want to offer our guests," said Michael Ma, Assistant Chief Executive (Business & Digital Technology Group) of Sentosa Development Corporation.

Across the festival period, visitors can explore more than 70 wellness sessions spanning sunrise yoga, seafront runs, strength training, breathwork, creative workshops and recovery experiences. Designed to be inclusive and accessible, the programme caters to all levels from those beginning their wellness journeys to seasoned practitioners.

At the heart of the daytime lineup is a roster of globally recognised fitness personalities. Joe Wicks, widely known as The Body Coach, brings his signature high energy approach to movement, while Chontel Duncan leads strength focused sessions grounded in performance and empowerment. Completing the lineup is Emi Wong, one of Asia's most influential digital fitness creators, known for workouts that have resonated with millions around the world.

As the sun sets, Glow shifts into a different rhythm, with live music anchoring the evening programme.

Multi-platinum global superstar Jason Derulo, whose era-defining hits and electrifying stage presence have captivated audiences around the world, will bring his explosive performance style to the Glow stage on Friday 17 July. Headlining Saturday 18 July are acclaimed Korean indie band Hyukoh, whose globally respected musicianship, authenticity and devoted international following, have established them as one of Asia's most compelling live acts and festival favourites across the world. Closing the festival on Sunday 19 July is Grammy-winning singer-songwriter Alessia Cara, celebrated for her soulful voice, powerful storytelling and chart-topping anthems that have inspired a generation.

Together the line up reflects Glow's evolving identity, where wellness and culture intersect in a shared, collective experience.

From 17 to 19 July, the Festival Grounds at Palawan Green will feature six immersive zones, anchored by the iconic Cupola Stage, which serves as both the festival's main stage and its central gathering point. Featuring the signature overhead canopy first introduced in 2019, this expansive 2,000 sqm space will host large-scale group movement sessions led by global fitness personalities by day, and performances by global music acts by night.

Surrounding this are five additional zones, each offering a distinct experience:

Dedicated movement spaces that will host a diverse lineup of classes throughout the festival, including yoga, pilates, barre, mobility training and functional fitness sessions.

A calming sanctuary focused on mental wellbeing, featuring guided meditation, breathwork and mindfulness sessions, alongside intimate conversations on topics such as stress management, sleep optimisation and sustainable wellbeing.

Makers Meadow

A creative corner offering hands-on workshops and craft experiences that encourage self-expression and mindful engagement.

A recovery-focused zone with ice baths, guided stretching, muscle recovery treatments and relaxation spaces designed to support post-workout recovery.

A curated mix of F&B concepts designed to fuel, refresh and indulge across the day. Highlights include Blue Smoke in collaboration with Bobby Supatra, bringing together a unique one-off menu created exclusively for Glow, alongside local favourites such as Dearborn, KORIO and Acai Collective.

Running throughout the festival period from 10 to 19 July, Glow will extend beyond the main Festival Grounds with a curated programme of wellness offerings that will be available across Sentosa's most iconic hospitality spaces including Raffles Sentosa Singapore, Sofitel Singapore Sentosa Resort & Spa, Amara Sanctuary Resort Sentosa, W Singapore Sentosa Cove and Shangri-La Rasa Sentosa.

Lilian Chee, Director of Sports, Singapore Tourism Board, said: "We are excited to partner with Exceed Sports & Entertainment to bring Glow Festival back for its fifth and most ambitious edition. This year's festival features expanded programmes, bringing together renowned wellness practitioners, innovative products and immersive experiences. This aligns with STB's Tourism 2040 vision to develop Singapore as a compelling destination, with wellness and quality leisure events identified as key growth opportunities. As wellness tourism continues to grow globally, this homegrown festival showcases Singapore's wide breadth of wellness activities while delivering meaningful experiences for locals and visitors, strengthening our position as a leading urban wellness destination."

Tickets for Glow Festival will be available across a range of options designed for individuals, groups and families, including Day Passes ($59-$75) for daytime wellness programming, Evening Passes ($89-$110) for sunset sessions and headline performances, and Weekend Passes ($199-$229) for full access across all festival days at the Palawan Green Festival Grounds, with free entry for children under six and reduced pricing for ages six to twelve. More information and tickets are available at https://glowfestival.sg/.

For media enquiries please get in touch with glowfest@wcommunications.sg.

The issuer is solely responsible for the content of this announcement.

Hashtags: #GlowFestival

BANGKOK, THAILAND - Media OutReach Newswire - 19 June 2026 - As geopolitical tensions reshape global trade, supply chains and investment flows, Thailand's long-standing reputation as a trusted and neutral regional partner could become one of its strongest competitive advantages, according to Distinguished Professor Andrew K. Rose, Dean of NUS Business School.

Speaking to the media during a visit to Bangkok, Professor Rose said economies with deep international trust and stable regional relationships are increasingly well positioned as businesses rethink where they invest, manufacture and expand.

"In a world where global alignments are shifting and supply chains are being redrawn, trust becomes a strategic asset," said Professor Rose. "Thailand has spent decades building strong relationships across Asia and beyond. That foundation becomes more valuable in periods of uncertainty."

A pivotal moment for Thailand

Thailand's current environment is demanding, and the International Monetary Fund's World Economic Outlook (April 2026) projects growth of 1.5 per cent in 2026.

Professor Rose noted that rising energy costs, softer long-haul tourism demand and rapid AI adoption are creating near-term pressure across key sectors of the Thai economy. However, he said periods of disruption often create the conditions for long-term competitive repositioning.

"The economies that emerge stronger are usually the ones that adapt earliest," as Professor Rose. "Leadership capability, agility and the ability to navigate change will determine who captures the next decade of growth."

The comments come as businesses across Southeast Asia accelerate investment in AI, digital transformation and workforce reskilling amid growing global economic fragmentation.

A 2026 Milieu Insight study of 3,000 workers across six Southeast Asian markets including Thailand found that 53 per cent ranked over-dependence on AI as their top concern, ahead of privacy risks and job displacement. This suggests that organisations in Thailand and across the region must do more to guide, not just deploy, new technology.

Building regional leadership capability

Addressing these challenges requires more than a policy response alone. Professor Rose emphasised that both multinationals and SMEs must build their adaptation strategies around talent and leadership development to power Thailand's growth engine.

Ms Usa Skulkerewathana, Senior Lecturer at NUS Business School, said Thai organisations should consider focusing on strengthening talent development and practical AI readiness rather than treating technology as a standalone solution.

"This is not a wait-and-see moment," said Ms Skulkerewathana. "Thai businesses that invest early in leadership, digital capability and workforce resilience will be better positioned to compete regionally and internationally."

Singapore's role as Asia's financial and educational hub offers Thai professionals and organisations a natural gateway to build regional leadership capability. Thai professionals and executives have, for decades, benefitted from NUS Business School's MBA, MSc and executive education programmes, including the Stanford-NUS Executive Programme and other senior leadership initiatives developed with global academic and industry partners. Thai enrolment has remained steady over the past five years as professionals seek regional exposure and globally benchmarked leadership training.

Thailand's "trust capital" is intact, and its position within a reorganising ASEAN is reinforced by the changes underway. The Thai institutions and business leaders that treat "trust capital" as a competitive asset, and build the leadership depth to deploy it, will define the country's next chapter of growth.

About NUS Business School

With 50,000 alumni and 60 global chapters, the National University of Singapore (NUS) Business School is known for providing management thought leadership from an Asian perspective, enabling its students and corporate partners to leverage global knowledge and Asian insights.

The school has consistently ranked first in Asia by independent publications and agencies, such as The Financial Times and Quacquarelli Symonds, in recognition of the quality of its programmes, faculty research and graduates.

The school is accredited by AACSB International (Association to Advance Collegiate Schools of Business) and EQUIS (European Quality Improvement System), endorsements that the school has met the highest standards for business education.

For more information about NUS Business School, please visit bschool.nus.edu.sg.

To discover our MBA, MSc or Executive Education courses, visit https://mscbiz.nus.edu.sg/, https://mba.nus.edu.sg/ or?https://executive-education.nus.edu.sg/

The issuer is solely responsible for the content of this announcement.

Hashtags: #NUSBusinessSchool

TEL AVIV, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q2 2026 Aide Memoire is available on the "Investors" page on its website.

Q2 2026 Aide Memoire

Teva has compiled this document with public information that was previously provided by Teva in order to assist investors ahead of second quarter 2026 results, which are expected to be released on Wednesday, July 29, 2026, at 7:00 a.m. ET, followed by a conference call at 8:00 a.m. ET on the same day. This document is based on Teva's prior results, management's previous commentary about Teva's business outlook and data from select independent sources.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva's commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients' needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.

Cautionary Note Regarding Forward-Looking Statements

This press release and the Aide Memoire document may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in this press release, and in our Quarterly Report on Form 10-Q for the first quarter of 2026, and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the sections captioned "Risk Factors" and "Forward-Looking Statements." Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

Teva Media Inquiries

TevaCommunicationsNorthAmerica@tevapharm.com

Teva Investor Relations Inquiries

TevaIR@Tevapharm.com

Copyright 2026 GlobeNewswire, Inc.

NDA submission supported by positive Phase 3 data recently published in JAMA Neurology.

Ecopipam is a first-in-class selective dopamine D1 receptor antagonist with a novel mechanism of action and has received FDA Orphan Drug and Fast Track designations

Ecopipam could be the first FDA-approved treatment option for pediatric Tourette syndrome in more than a decade, if approved.

TEL AVIV, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ecopipam, a first-in-class investigational therapy for the treatment of pediatric Tourette syndrome.

"The NDA submission for ecopipam is a significant milestone for a potential first-in-class treatment option in pediatric Tourette syndrome," said Eric Hughes, M.D., Ph.D., Executive Vice President, Global R&D and Chief Medical Officer of Teva. "This reflects the momentum in our innovative pipeline through our recent acquisition of this important asset, and advances our Pivot to Growth strategy and commitment to bringing differentiated medicines for patients."

The NDA submission is supported by positive Phase 3 data recently published in JAMA Neurology, which showed that ecopipam significantly delayed time to relapse compared with placebo in pediatric patients with Tourette syndrome who had achieved a clinical response during the open-label treatment period. In the study, ecopipam demonstrated a statistically significant benefit on the primary efficacy endpoint in pediatric patients (p = 0.008) and was generally well tolerated, with the most common adverse events related to ecopipam therapy including somnolence, insomnia, anxiety, fatigue and headache.

About Tourette Syndrome

Tourette syndrome is a chronic neuro-developmental disorder character by involuntary motor and vocal tics beginning in childhood, often between 5 and 10 years of age. For people living with Tourette syndrome, symptoms can be frequent, visible, and disruptive, affecting everyday life. Despite the current treatment options available, many patients continue to experience inadequate treatment control or treatment-limiting side effects, underscoring the need for additional options.

About ecopipam

Ecopipam is a first-in-class investigational therapy designed to block dopamine signaling at the D1 receptor. D1 receptor hypersensitivity may contribute to repetitive and compulsive behaviors associated with Tourette syndrome.

Ecopipam has received Orphan Drug and Fast Track designations from the FDA for the treatment of pediatric patients with Tourette syndrome. Orphan Drug designation is reserved for patient populations of 200,000 or fewer.

Results from the Phase 3 study in Tourette syndrome were recently published in JAMA Neurology. The primary efficacy endpoint in the study was time to relapse (based on YGTSS-TTS scale) for pediatric patients who were stable and responding to ecopipam. The study showed statistical significance between ecopipam and placebo for the primary efficacy endpoint in pediatric patients (p = 0.008). Ecopipam was generally well-tolerated in the study and the most common adverse events related to ecopipam therapy were somnolence (n = 24 [11.1%]), anxiety (n = 21 [9.7%]), headache (n = 21 [9.7%]), insomnia (n = 19 [8.8%]), tic (n = 17 [7.9%]), and fatigue (n = 14 [6.5%]). 

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva's commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients' needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.

Teva Media Inquiries: TevaCommunicationsNorthAmerica@tevapharm.com

Teva Investor Relations Inquiries: TevaIR@Tevapharm.com

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause Teva's future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements.

All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. In some cases, you can identify these forward-looking statements by the use of words such as "should," "expect," "anticipate," "developing," "target," "may," "expand," "intend," "plan," "believe" and other words and terms of similar meaning and expression in connection with any discussion of future performance. Important factors that could cause or contribute to such differences include risks and uncertainties relating to: our ability to successfully develop, obtain regulatory approval for and commercialize ecopipam; our ability to successfully compete in the marketplace including our ability to develop and commercialize ecopipam and additional pharmaceutical products; our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development, and to execute on our organizational transformation and to achieve expected cost savings; our significant indebtedness, which may limit our ability to incur additional indebtedness, engage in additional transactions or make new investments; and other factors discussed in this press release, in our Quarterly Report on Form 10-Q for the first quarter of 2026 and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the sections captioned "Risk Factors" and "Cautionary Note Regarding Forward Looking Statements." Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

Copyright 2026 GlobeNewswire, Inc.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

TEL AVIV, Israel and PARSIPPANY, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2026 financial results on Wednesday, July 29, 2026, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET.

In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin.

A live webcast of the call will be available on Teva's website at: https://ir.tevapharm.com/Events-and-Presentations.

Following the conclusion of the call, a replay of the webcast will be available within 24 hours on Teva's website.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva's commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients' needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.

Cautionary Note Regarding Forward-Looking Statements

This Document and the presentation at the conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as "should," "expect," "anticipate," "estimate," "target," "may," "project," "guidance," "intend," "plan," "believe" and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace; our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development, to sustain and focus our portfolio of generic medicines, and to execute on our organizational transformation and to achieve expected cost savings; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in our Quarterly Report on Form 10-Q for the first quarter of 2026, and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the sections captioned "Risk Factors" and "Forward Looking Statements." Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

Teva Media Inquiries

TevaCommunicationsNorthAmerica@tevapharm.com

Teva Investor Relations Inquiries

TevaIR@Tevapharm.com

Copyright 2026 GlobeNewswire, Inc.

Platform yang dirancang khusus untuk operator jaringan yang memungkinkan AI di lokasi yang mandiri, SLM yang dibangun khusus operator, akses ke model mutakhir yang diatur kebijakan, dan keamanan AI zero trust, semuanya pada satu platform pembayaran token dan jaminan layanan

RICHARDSON, Texas, June 18, 2026 (GLOBE NEWSWIRE) -- Mavenir hari ini mengumumkan Platform AI Terintegrasi yang dikembangkan bersama dengan Red Hat yang memungkinkan operator jaringan untuk memonetisasi AI sebagaimana layaknya mereka memonetisasi data; melalui paket penggunaan berbasis token, ditagihkan ke tagihan telepon, dengan kendali penuh atas penetapan harga, perjanjian tingkat layanan (SLA), dan model yang mendukung setiap interaksi.

Platform AI Terintegrasi ini akan beroperasi di tiga model: layanan AI bermerek operator untuk pelanggannya sendiri; sebagai lapisan infrastruktur AI yang mendukung penerapan grid AI operator; dan sebagai platform AI terkelola bagi operator untuk menawarkan kemampuan AI kepada pelanggan perusahaan dalam bentuk penggunaan berbasis token.

Menggunakan Red Hat AI sebagai platform terpadu yang menggabungkan kemampuan AI yang beroperasi dengan infrastruktur Kubernetes yang didukung oleh Red Hat OpenShift, Platform AI Terintegrasi Mavenir memberdayakan operator dengan arsitektur yang fleksibel dan mengutamakan kedaulatan. Ini memungkinkan operator untuk memanfaatkan model di lokasi dan model bahasa kecil (SLM) khusus yang dapat menangani berbagai jenis kasus penggunaan, sekaligus memperoleh manfaat dari konektivitas selektif dan diatur kebijakan ke model mutakhir untuk tugas yang menuntut kemampuan penalaran canggih. Operator mengendalikan model mana yang menangani permintaan, pihak yang membayarnya, dan cara penagihannya.

Pasar layanan AI global menghasilkan aliran pendapatan baru yang dapat dimanfaatkan secara khusus oleh operator jaringan. Penggunaan AI berbasis token, model unit yang mendukung setiap interaksi model bahasa besar, meniru paradigma penagihan data seluler yang telah dikuasai oleh operator selama beberapa dekade. Paket token AI bulanan, kuota perusahaan per departemen, dan tingkat yang didukung SLA untuk layanan AI yang disediakan operator mewakili lapisan monetisasi yang baru secara struktural di atas konektivitas yang sudah ada.

Untuk mewujudkan kesempatan ini, operator memerlukan infrastruktur AI tingkat produksi yang mengendalikan komputasi di lokasi yang mandiri, perutean model cerdas, pengukuran akurat berbasis token, jaminan layanan tingkat operator, dan integrasi penagihan. Sayangnya, tidak ada satu model penerapan yang sesuai untuk setiap kasus penggunaan. Kasus penggunaan rutin sebaiknya ditangani oleh SLM yang dimiliki oleh operator karena alasan biaya dan kedaulatan. Tugas penalaran yang rumit mungkin memerlukan akses selektif ke model mutakhir. Dibangun dalam kerja sama dengan Red Hat, Platform AI Terintegrasi milik Mavenir mendukung kedua mode di bawah satu kebijakan dan kerangka pembayaran, sehingga menghasilkan arsitektur hibrida bagi operator yang memaksimalkan biaya tanpa mengorbankan kemampuan yang paling dibutuhkan.

Platform AI Terintegrasi menggabungkan platform perangkat lunak AI milik Mavenir dengan kemampuan Kubernetes dan AI perusahaan milik Red Hat pada perangkat keras tervalidasi dari mitra pihak ketiga. Hasilnya adalah infrastruktur AI berbasis cloud tingkat operator yang dapat diterapkan oleh operator di lokasi yang memiliki kedaulatan data yang ditingkatkan. Arsitekturnya dirancang hibrida, menggunakan model di lokasi bawaan dan model sumber terbuka untuk melayani sebagian besar lalu lintas, dengan router model milik Mavenir menyediakan akses terukur dan diatur kebijakan ke model eksternal yang mutakhir untuk kasus penggunaan yang memerlukan kemampuan penalaran atau multimodal tingkat lanjut. Platform tersebut memungkinkan operasi dan orkestrasi agen, perutean model cerdas, dan optimasi token, kemampuan platform-as-a-service (PaaS) AI dan MLOps yang didukung oleh Red Hat AI; pembayaran dan penagihan token melalui Mavenir Digital Enablement, jaminan layanan loop tertutup, identitas zero trust, autentikasi dan keamanan AI, semuanya didukung oleh infrastruktur kontainer tingkat operator Red Hat OpenShift, platform aplikasi cloud hibrida terkemuka di industri yang didukung Kubernetes.

Platform ini mendukung tiga model operasi yang berbeda, memberi operator fleksibilitas dalam cara mereka menerapkan dan memonetisasi AI:

Platform AI Perusahaan: Operator menawarkan akses terukur untuk model AI, sumber daya komputasi, dan alat bantu AI kepada pelanggan perusahaan sebagai layanan bernilai tambah di samping kontrak konektivitas yang sudah ada. Pelanggan perusahaan menerapkan aplikasi mereka sendiri atau mengonsumsi API AI berdasarkan pemakaian. Operator menyediakan SLA infrastruktur dan platform; SLA aplikasi perusahaan diatur oleh perjanjian layanan khusus antara operator dan pelanggan.

Infrastruktur Grid AI: Operator menggunakan platform sebagai infrastruktur komputasi dan AI untuk penerapan grid AI, menghosting aplikasi AI yang terintegrasi dalam jaringan serta beban kerja pihak ketiga pada infrastruktur yang dikendalikan oleh operator. Platform menyediakan jaminan ketersediaan tingkat infrastruktur; kinerja aplikasi dan tingkat layanan adalah tanggung jawab pemilik aplikasi kecuali jika operator mengemas aplikasi tersebut sebagai layanan terkelola miliknya sendiri.

Layanan AI Operator: Operator menjalankan platform untuk menghadirkan produk dan layanan yang didukung AI kepada pelanggannya sendiri. Hal ini termasuk paket asisten AI yang ditagih berdasarkan penggunaan token, layanan jaringan yang disempurnakan AI, dan aplikasi AI bermerek operator. Operator memiliki hubungan komersial, menetapkan SLA, dan memiliki kendali penuh atas penetapan harga, merek, dan kualitas layanan.

Platform tersebut dirancang untuk memberikan hasil nyata, termasuk:

*Aliran pendapatan baru dari AI melalui paket token gabungan dari tingkat konsumen dasar hingga kuota perusahaan tak terbatas.

*Ekonomi AI dapat diprediksi dengan mengalihkan sebagian besar lalu lintas ke model di lokasi menggunakan pembatasan pengeluaran ketat terhadap penggunaan model mutakhir apa pun.

*Kedaulatan data yang dirancang sejak awal, dengan semua data pelanggan dan bobot model tetap berada di infrastruktur operator selama operasi normal.

*SLA kontrak untuk layanan AI yang dikelola operator didukung oleh jaminan layanan loop tertutup, dengan jaminan ketersediaan tingkat platform yang mencakup beban kerja perusahaan dan Grid AI.

*Jalur cepat untuk memperoleh pendapatan melalui panduan penerapan yang telah tervalidasi sebelumnya, dengan penerapan produksi Mavenir sendiri yang berperan sebagai arsitektur referensi.

*Keamanan tingkat perusahaan melalui pengendalian identitas zero trust dan perlindungan ancaman khusus AI yang memenuhi

persyaratan kepatuhan lingkungan komunikasi yang diregulasi.

"Operator mengamati pendapatan dari AI mengalir ke hyperscaler dan platform pihak ketiga selagi mereka menyediakan konektivitas yang membuat semuanya menjadi mungkin. Hari ini, hal ini berubah. Platform AI Terintegrasi yang dikembangkan melalui kolaborasi Mavenir dan Red Hat menyediakan infrastruktur kepada operator untuk menjadi penyedia layanan AI secara mandiri. Operator mendapatkan kendali penuh atas model dan data, monetisasi berbasis token akurat yang terintegrasi dengan BSS yang ada, dan jaminan layanan untuk mendukung layanan AI terkelola mereka sendiri dengan SLA kontraktual. Baik operator meluncurkan layanan AI berbasis langganan, membangun infrastruktur grid AI mereka, maupun menawarkan kemampuan AI ke pelanggan perusahaan berbasis penggunaan, platform tersebut menyediakan kendali komersial dan operasional untuk melakukannya dalam skala operator. Untuk kasus penggunaan yang paling menuntut, platform juga menyediakan akses ke model mutakhir yang diatur oleh kebijakan, sehingga operator tidak pernah dibatasi oleh model yang dijalankan di lokasi mereka. Hal ini dibangun dari dasar untuk memenuhi persyaratan monetisasi operator." Bejoy Pankajakshan, Chief Technology dan Strategy Officer, Mavenir

"Di dunia masa kini yang digerakkan AI, operator jaringan sekarang semakin memerlukan ketersediaan tinggi, kedaulatan data, dan keandalan tingkat operator untuk meningkatkan skala AI bagi jutaan pelanggan. Bekerja sama dengan Mavenir, kami menyediakan solusi terintegrasi yang didukung oleh fondasi berbasis Kubernetes yang didukung oleh Red Hat AI, yang menghadirkan kemampuan MLOps, inferensi vLLM, dan AgentOps. Arsitektur hibrida ini memungkinkan operator menjalankan model di lokasi secara mandiri untuk sebagian besar lalu lintas mereka dan secara selektif terhubung ke model mutakhir untuk tugas yang memerlukannya, semua ini melalui satu kerangka kebijakan dan penagihan. Bersama-sama, kami menyediakan jalur bagi operator dari eksperimen AI hingga monetisasi AI tanpa perlu membangun ulang mdel operasi mereka." Chris Wright, Chief Technology Officer dan Senior Vice President, Global Engineering, Red Hat

Bergabunglah bersama Mavenir di DTW Ignite 2026, 23?25 Juni - stan #334:

Di DTW Ignite, Mavenir akan menunjukkan bagaimana perangkat lunak yang mengintegrasikan AI sejak awal memberikan hasil jaringan yang nyata: mewujudkan inovasi jaringan 5G Core, membuka pendapatan layanan baru di satu sisi dan secara radikal meningkatkan efisiensi operasional di sisi lain.

Tentang Mavenir 

Mavenir menghadirkan jaringan cerdas, otomatis, dan dapat diprogram melalui pengembangan solusi perangkat lunak yang mengutamakan telekomunikasi, berbasis cloud, dan yang mengintegrasikan AI sejak tahap perancangan, untuk operator seluler. Keahlian mendalam perusahaan ini di bidang telekomunikasi telah terbukti melalui penerapan dengan lebih dari 300 operator secara global di lebih dari 120 negara, yang bersama-sama melayani lebih dari 50% pelanggan dunia. Mavenir menggabungkan pengalaman telekomunikasinya yang mendalam dengan keahlian cloud dan IT serta keahlian sains data yang sangat penting untuk memecahkan tantangan nyata yang dihadapi pelanggan. Solusi perangkat lunaknya yang berdampak nyata mengintegrasikan AI sejak awal, menghadirkan masa depan berbasis AI dan evolusi operator di perusahaan teknologi. Untuk informasi lebih lanjut, kunjungi www.mavenir.com

Kontak Humas:

Mavenir:

Emmanuela Spiteri

PR@mavenir.com

Copyright 2026 GlobeNewswire, Inc.

Hero performs full end-to-end report development, Application configuration, and token management, closing tickets at no marginal cost on top of the platform fee while customers keep their existing systems, controls, and access model.

Pitch Notes:

Dayos is an AI-native platform company in Singapore. Its platform, Hero, automates the application-managed services work for Oracle and Workday that enterprises have historically outsourced: configuration, report development, reconciliations, transaction entry, monitoring, and incident resolution. The Athena release is now generally available.

The story for editors is the economic model, not just the technology. AMS providers bill per ticket or per hour; Hero closes tickets at no marginal cost on top of the platform fee, so every ticket Hero closes is one the incumbent provider does not bill for. Customers keep their existing Oracle and Workday systems, their controls, and their role-based access model rather than riping and replacing.

Dayos is ISO 42001 and SOC 2 Type 2 certified and was published as a reference deployment in the IMDA Model AI Governance Framework for Agentic AI. Founder and CEO Brad McElhannon spent 20+ years in enterprise Oracle implementation and led Finance Engineering at Robinhood through its IPO. Available for interviews, briefings, and live demonstrations of Hero.

SINGAPORE - Media OutReach Newswire - 18 June 2026 - Dayos Pte. Ltd., the Singapore-based AI company, today announced the general availability of Athena, the latest release of Hero, its agentic platform for Oracle and Workday support. Hero is a direct replacement for traditional Application Managed Services (AMS) contracts - not a tool layered on top - and is available to enterprise customers immediately via Dayos' Starter and Pro plans.

The release addresses four structural problems with the AMS model that enterprises running Oracle and Workday have lived with for two decades.

Time to deploy. Traditional AMS engagements take months to scope, onboard, and ramp to full coverage. Athena Starter deploys in two weeks - from contract execution to production agents running inside the customer's Oracle or Workday tenant.

Quality of work. Hero's agents reason through tickets in the customer's actual tenant - exploring, planning, and validating before posting. Report development tickets, historically the worst offenders on enterprise SLA reports, complete 70% faster on Hero. Plain English in, validated SQL out, executed inside the tenant.

Long-term support drag. Hero reduces Oracle ticket backlogs by 50% in the first 30 days for Starter customers, with a sustained 60% reduction in the active ticket queue by the end of year one for Pro customers. SLAs across customer engagements run 50% faster. Every ticket Hero closes is a ticket the customer's AMS provider does not bill for.

Proof. Dayos used Hero internally to retire its own ServiceNow ITSM environment in 45 days, with 60% of Tier 1 tickets now resolved autonomously. The deployment is documented as a reference case in Section 2.1 of the IMDA Model AI Governance Framework for Agentic AI, published by Singapore's Infocomm Media Development Authority at ATxSG in May 2026, alongside case studies from AWS, DBS, Google, Workday, OCBC, Tencent, PwC, and GovTech.

"AMS providers bill per ticket or per hour. Hero closes tickets at no marginal cost on top of the platform fee. Every ticket Hero closes is one your AMS provider doesn't bill for," said Brad McElhannon, Founder and CEO of Dayos.

AVAILABLE NOW AND AHEAD

Athena Starter is available at USD 60,000 per year, delivering 50% Oracle ticket backlog reduction in 30 days, 70% faster report development, and 50% faster SLAs. Athena Pro is available at USD 150,000 per year, adding custom agent development and a contractually committed 60% sustained reduction in the active ticket queue by the end of year one. Plan details and outcome breakdowns by tier are at dayos.com/plans (https://www.dayos.com/plans).

The Athena Hero release ships with full support for Oracle and Workday. SAP availability is targeted for January 2027.

Hero is built on Google's Agent Development Kit (ADK) with Gemini as the lead reasoning model, and operates under ISO 42001-aligned governance with SOC 2 Type II controls. Athena enters general availability, with active enterprise deployments across the Asia-Pacific region.

About Dayos

Dayos is an AI-native platform company headquartered in Singapore. Its platform, Hero, automates the Oracle and Workday application-managed services work that enterprises have historically outsourced, including configuration, report development, reconciliations, transaction entry, monitoring, and incident resolution. Rather than replacing a customer's systems, Hero works inside their existing Oracle and Workday environments and respects their established controls and role-based access model.

Dayos is ISO 42001 and SOC 2 Type 2 certified and was published as a reference deployment in the IMDA Model AI Governance Framework for Agentic AI. The company was founded by Brad McElhannon, who spent more than 20 years in enterprise Oracle implementation across 200+ clients and led Finance Engineering at Robinhood through its IPO. Learn more at www.dayos.com.

The issuer is solely responsible for the content of this announcement.

Hashtags: #AgenticAI #Oracle #Workday #SAP #EnterpriseAI #AMS

My ENet App consolidates all subscriber services, eSIM provisioning and payments into one platform, with a built-in digital wallet unlocking new revenue streams for ENet

RICHARDSON, Texas, June 18, 2026 (GLOBE NEWSWIRE) -- Mavenir, the cloud-native network software provider, today announced the launch of My ENet App, a unified digital platform developed for Guyana's multi-service operator ENet.

The app brings together mobile voice, SMS, data, broadband, fixed line and IPTV into a single, seamless digital experience for ENet's consumer and enterprise customers: replacing multiple disconnected applications with one integrated platform covering onboarding, self-service, payments and eSIM provisioning.

ENet is one of Guyana's leading telecommunications providers, serving consumers and enterprises with mobile, broadband, fixed voice and IPTV services across the country. The launch of My ENet App marks one of the most comprehensive digital service consolidations by a Caribbean operator.

Until now, ENet customers had to navigate multiple apps across different BSS platforms to manage their services, a fragmented experience that the new app eliminates entirely.

The unified digital experience gives all customers a single digital touchpoint for onboarding, eSIM provisioning, self-service, loyalty and rewards, payments, and adding services via the ENet digital shop.

Vishok Persaud, CEO, ENet, said: "The new My ENet App delivers a simple, integrated experience for our customers, while creating opportunities for future digital services and innovation. Our continued partnership with Mavenir is another major step in reinforcing ENet's position as a technology and digital services leader in Guyana."

A core differentiator of My ENet App is its central digital wallet: a single cash account that spans all ENet services. Beyond bill payments and recharges, the wallet gives ENet the foundation to process third-party payments, opening the door to new fintech-style revenue streams and digital partnerships.

Built on the Mavenir Digital Enablement (MDE) platform, the app was delivered using Mavenir's Agile Delivery Squad (ADS) model, providing ENet with a dedicated development team for ongoing app evolution and system integration. My ENet App is available on both iOS and Android.

Sandeep Singh, SVP & General Manager, Business Solutions, Mavenir, said: "My ENet App is a powerful example of what our Digital Enablement platform can deliver for operators ready to move beyond connectivity. By unifying multiple services and a digital wallet in one experience, ENet can simplify the customer journey while unlocking entirely new monetization models. This is the Telco-to-TechCo transformation in action."

The launch builds on a long-standing partnership between the two companies. In 2023, ENet launched new 4G and 5G services in Guyana powered by Mavenir's cloud-native IMS and Digital BSS, a milestone in the country's mobile network evolution. My ENet App represents the next chapter in that collaboration.

Notes to the Editor:

- DTW Ignite 2026, 23-25 June - booth #334:

At DTW Ignite, Mavenir will be showcasing how AI-by-design software delivers tangible network outcomes: unleashing 5G Core network innovation, unlocking new service revenues on the one hand and radically improving operational efficiency on the other. Demo booking is available here.

- About My ENet: Everything ENet. One app.

My ENet is your all-in-one hub for managing your ENet world - built around the way you live, work, and connect. Whether recharging, paying a bill, or signing up for the first time, everything you need is right here - no lines, no hassle, no switching between apps.

What you can do with My ENet:

1. Manage your services - View and control all your ENet accounts and plans from a single, unified dashboard. Everything in one place, always up to date.

2. Pay your way - Make fast, secure payments using your E-Wallet or credit card. Pay bills, recharge, and more - without leaving the app.

3. Get an eSIM instantly - Sign up for eSIM directly from your device. Skip the store visit and get connected in minutes, wherever you are.

Built for what's next - My ENet is constantly evolving. Every update brings new features, smoother performance, and more of your ENet services into one seamless experience.

Download My ENet App:

https://play.google.com/store/apps/details?id=gy.enetworksapp

https://apps.apple.com/us/app/my-enet/id1618927353

About Mavenir

Mavenir is enabling intelligent, automated, programmable networks through the development of telco-first, cloud-native, AI-by-design software solutions for mobile operators. The company's deep telco domain expertise has been proven through deployments with 300+ operators globally in over 120 countries, which together serve more than 50% of the world's subscribers. Mavenir combines its deep telco experience with the cloud and IT expertise and data science skillsets essential to solving real customer challenges. Its proven software solutions are AI by design, delivering the AI-native future and operators' evolution to TechCos.

For more information, please visit www.mavenir.com

Mavenir PR Contacts:

Emmanuela Spiteri

PR@mavenir.com

Copyright 2026 GlobeNewswire, Inc.

Workvivo HQ menggabungkan komunikasi, pengetahuan, dan AI ke dalam satu platform yang dirancang untuk membantu setiap karyawan menemukan jawaban, menyelesaikan pekerjaan, dan tetap terhubung

CORK, Irlandia, June 18, 2026 (GLOBE NEWSWIRE) -- Workvivo by Zoom hari ini memperkenalkan Workvivo HQ, kantor pusat digital berbasis AI yang memadukan komunikasi, pengetahuan, dan tindakan ke dalam satu platform cerdas. Dirancang untuk seluruh karyawan, mulai dari pekerja di lini depan hingga tim korporat, Workvivo HQ menyediakan satu ruang terpadu bagi setiap organisasi untuk menyelesaikan pekerjaan.

Workvivo HQ diluncurkan pada momentum yang tepat, ketika berbagai organisasi gencar berinvestasi di bidang AI dan mencari cara tepercaya untuk membantu setiap karyawan memanfaatkan potensinya. Dikembangkan dari teknologi AI Zoom, platform ini menciptakan satu kantor pusat digital cerdas yang memungkinkan karyawan memulai hari, menemukan informasi yang dibutuhkan, menyelesaikan pekerjaan, dan tetap mengetahui perkembangan terbaru tanpa perlu beralih di antara berbagai alat. Dengan menghadirkan AI langsung ke dalam alur kerja sehari-hari, Workvivo HQ membantu organisasi menjembatani kesenjangan antara investasi AI dan dampak nyata bagi tenaga kerja.

"Setiap karyawan berhak memiliki kantor pusatnya sendiri," ucap John Goulding, CEO dan Co-Founder Workvivo. "Masa depan dunia kerja bukanlah alat AI lainnya. Masa depan itu adalah pengalaman karyawan yang menyatukan komunikasi, pengetahuan, dan AI tanpa kendala. Workvivo HQ menghadirkan kantor pusat digital bagi organisasi di era AI, satu tempat bagi setiap karyawan untuk menemukan jawaban, mengambil tindakan, dan tetap terhubung dengan hal yang paling penting."

Era Baru untuk Pengalaman Karyawan: Menghadirkan Rumah Bagi Pekerjaan

Peluncuran Workvivo HQ menggambarkan evolusi paling signifikan platform Workvivo sejak bergabung dengan Zoom pada tahun 2023 dan langkah maju baru yang berani bagi pengalaman karyawan di era AI. Hal ini mencerminkan perubahan mendasar dalam cara organisasi memandang pengalaman karyawan, dari tempat tujuan untuk komunikasi dan keterlibatan menjadi fondasi bagi produktivitas, pengetahuan, dan cara kerja yang didukung AI.

Workvivo HQ didukung oleh AI Zoom dan pendekatan federatifnya, fondasi yang sama yang mendukung ZoomMate. Pendekatan ini memanfaatkan model AI milik Zoom sendiri, serta model dari perusahaan AI terkemuka seperti OpenAI, Anthropic, dan lainnya. Kecerdasan AI diintegrasikan ke dalam pengalaman karyawan sehingga AI terasa sebagai bagian alami pekerjaan sehari-hari, bukan lagi platform terpisah yang berdiri sendiri.

Dengan Workvivo HQ, karyawan dapat:

Mengakses pengetahuan, kebijakan, dokumen, dan keahlian perusahaan dengan cepat

Memahami sentimen karyawan dan tren di tempat kerja melalui analisis SDM berbasis AI

Mengikuti perkembangan terbaru melalui ringkasan buatan AI, rekap, dan pembaruan yang dipersonalisasi

Menyusun komunikasi, pengumuman, dan konten dengan lebih cepat melalui bantuan penulisan berteknologi AI

Menjangkau karyawan di mana pun mereka berada, mulai dari garis depan hingga kantor korporat, melalui pengalaman berteknologi AI yang dipersonalisasi

Mengubah pertanyaan menjadi pekerjaan yang terselesaikan dengan HQ Agent, yang dapat mengambil tindakan di berbagai sistem terhubung

Memperkenalkan HQ Agent

Workvivo juga memperkenalkan HQ Agent, lapisan AI agentik yang memperluas kemampuan Workvivo HQ di luar platform itu sendiri dan menghubungkan karyawan dengan ekosistem teknologi perusahaan yang lebih luas.

Dengan terhubung ke lebih dari 60 sistem perusahaan, termasuk Gmail, Google Drive, Jira, Salesforce, ServiceNow, Workday, dan aplikasi bisnis lainnya, HQ Agent dapat memahami permintaan, mengambil informasi, mengoordinasikan pekerjaan di berbagai sistem, serta mengambil tindakan atas nama karyawan. Workvivo HQ membantu karyawan berkomunikasi dan menemukan jawaban, sedangkan HQ Agent membantu mereka menindaklanjuti jawaban tersebut.

"Ketika kami mulai merancang Workvivo HQ, kami tidak sekadar bertanya bagaimana menambahkan lebih banyak AI ke tempat kerja. Kami bertanya bagaimana membuat pekerjaan terasa lebih sederhana," kata Andrea Graham, Head of Product and Engineering Workvivo. "Hasilnya adalah pengalaman yang menyatukan komunikasi, pengetahuan, dan tindakan dalam satu tempat, membantu karyawan memangkas waktu untuk mencari informasi dan menggunakan lebih banyak waktu untuk menyelesaikan pekerjaan bermakna."

Dirancang untuk Adopsi AI di Seluruh Tenaga Kerja

Saat ini, Workvivo melayani lebih dari 10 juta pengguna di seluruh dunia dan dipercaya oleh lebih dari 1.300 organisasi di lebih dari 200 negara dan wilayah. Dengan tingkat adopsi dan keterlibatan yang terdepan di industri, Workvivo memiliki posisi unik untuk membantu organisasi menerapkan AI di seluruh tenaga kerja mereka.

Workvivo HQ juga menyatukan berbagai kemampuan Seer by Workvivo dengan mengintegrasikan praktik pengumpulan masukan karyawan dan analisis SDM langsung ke dalam pengalaman karyawan. Dengan menggabungkan komunikasi, wawasan tenaga kerja, dan AI ke dalam satu platform, organisasi dapat memahami secara lebih mendalam kebutuhan karyawan, sekaligus membekali para pemimpin dengan alat untuk mendorong keterlibatan, mendukung perubahan, dan mengambil keputusan yang lebih matang.

Peluncuran ini dilakukan saat berbagai organisasi berupaya meningkatkan adopsi AI di kalangan tenaga kerja yang semakin beragam. Riset terbaru yang dibuat atas permintaan Workvivo, The Frontline AI Gap**, menemukan adanya kesenjangan signifikan dalam adopsi AI di tempat kerja. Sebanyak 62% pekerja kantoran melaporkan frekuensi penggunaan AI yang rutin atau sesekali, dibandingkan dengan hanya 32% pekerja di garis depan.

Berbeda dengan banyak solusi AI untuk perusahaan yang terutama untuk memenuhi kebutuhan pekerja kantoran, Workvivo HQ menghadirkan pengalaman lengkap berteknologi AI di desktop dan perangkat seluler. Kemampuan ini membantu organisasi menutup kesenjangan tersebut dan memperluas jangkauan manfaat AI bagi setiap karyawan, termasuk pekerja di garis depan dan pekerja non-kantoran.

"Organisasi yang berhasil menerapkan AI adalah organisasi yang mampu membuat teknologi ini bermanfaat, mudah diakses, dan relevan bagi setiap karyawan," kata Goulding. "Transformasi AI tidak boleh terbatas pada pekerja berbasis pengetahuan. Transformasi ini harus menjangkau seluruh tenaga kerja. Workvivo HQ dirancang untuk membantu mewujudkan hal itu."

Untuk mempelajari lebih lanjut tentang Workvivo HQ, kunjungi www.workvivo.com/hq.

**Pada tahun 2026, Workvivo menugaskan sebuah lembaga riset independen, TrendCandy, untuk menyurvei 4.736 pekerja garis depan dan pekerja kantoran di berbagai industri dan negara. Responden diseleksi dan direkrut melalui panel sampel B2B terpilih di seluruh dunia, dengan menerapkan berbagai pemeriksaan kualitas, termasuk penyaringan ganda, perekrutan dengan metode buta ganda, pemeriksaan kualitas keterlibatan, pengacakan, serta praktik metodologi terbaik lainnya.

Tentang Workvivo by Zoom

Workvivo by Zoom adalah platform pengalaman karyawan berbasis AI yang terdepan di pasar untuk perusahaan global. Platform ini menyatukan komunikasi, keterlibatan, pengetahuan, dan analisis SDM ke dalam satu platform yang mengutamakan pengalaman seluler serta sejak awal dirancang dengan fokus pada manusia dan adopsi pengguna. Dengan mengelola pengalaman karyawan di berbagai kanal dan sistem secara terpadu, Workvivo membantu organisasi berkomunikasi dengan jelas, menampilkan jawaban cepat melalui AI, dan mengubah wawasan menjadi tindakan dalam skala besar.

Diakui sebagai Pemimpin dalam The Forrester Wave: Intranet Platforms, Pemimpin dalam Gartner Magic Quadrant untuk Intranet Packaged Solutions, serta Pilihan Pelanggan di Gartner Peer Insights, Workvivo mendukung lebih dari 10 juta pengguna di seluruh dunia di berbagai merek global terkemuka, termasuk Amazon, Delta, Motherson, White Castle, Heineken, Bupa, Ryanair, dan Verizon. Workvivo, yang didirikan pada 2017 dan diakuisisi oleh Zoom pada tahun 2023, terus mendefinisikan ulang cara organisasi menghubungkan dan menyelaraskan tenaga kerja mereka. Untuk mengetahui informasi selengkapnya, kunjungi http://www.workvivo.com.

Kontak Media

Vineetha Pathrose

press@workvivo.com

Copyright 2026 GlobeNewswire, Inc.

BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- Curium is pleased to announce that it has prevailed in the patent dispute brought by Novartis subsidiary Advanced Accelerator Applications against Curium concerning Curium's Lutetium Lu 177 dotatate product.

In the court decision issued yesterday by the Delaware U.S. District Court, Justice Noreika adjudicated that all relevant patent claims asserted by Novartis/AAA are invalid and not infringed by Curium, representing a complete victory for Curium.

This favorable court decision paves the way for Curium's plans to launch its Lutetium Lu 177 dotatate product in the U.S. and commercialize a therapy for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors in adults across the United States.

Renaud Dehareng, Curium's group chief executive officer, said: "We are pleased with the court's decision. Curium is focused on building a durable theranostics platform that pairs our diagnostic leadership with targeted radioligand therapies - and doing so with the operational discipline required to serve patients reliably at scale."

Michael Patterson, Curium's North American chief executive officer, said: "This outcome brings Curium a step closer in our mission to deliver what patients, clinicians and health systems need: timely access to critical targeted radiopharmaceuticals. Curium has more than 100 years of experience in nuclear medicine and a long-standing commitment of over 30 years to the NET community, supplying diagnostic products that help detect neuroendocrine tumors today and a pipeline of investigational drugs in development."

About Curium

Curium is an independent global radiopharmaceutical leader driving innovation in nuclear medicine to change patients' lives. With an industry heritage dating back more than 100 years, Curium has proven expertise in the development, manufacturing and supply of radiopharmaceuticals that transform the way cancer is diagnosed and treated. Headquartered in Boston with offices around the world, Curium's mission is to find new and better ways to diagnose and treat cancer.

With a global footprint that extends to more than 70 countries, a skilled and dedicated team of over 3,800 employees, and four manufacturing sites, Curium is uniquely qualified to meet the significant supply and distribution of established products that underlie success in the radiopharmaceuticals market. Curium's global leadership is embodied in a diverse and extensive portfolio of over 45 products that advance patient care.

Curium's pioneering legacy in nuclear medicine is the foundation of the company's dedication to innovation and portfolio expansion to cancer therapeutics, particularly in neuroendocrine tumors and with a late-stage pipeline exploring opportunities in prostate cancer.

To learn more, visit www.curiumpharma.com.

Inquiries:

Curium Group

Camilla Campell

VP, Head of Global Communications

Camilla.campbell@curiumpharma.com

Copyright 2026 GlobeNewswire, Inc.

AREZZO, Italy, June 18, 2026 (GLOBE NEWSWIRE) -- Italpreziosi, a leading company in the precious metals and investment gold sector, is proud to announce its collaboration with Ducati to celebrate a historic milestone: the 100th anniversary of the iconic motorcycle manufacturer from Borgo Panigale.

On the occasion of World Ducati Week 2026, taking place from July 3 to 5 at the Misano World Circuit Marco Simoncelli, Italpreziosi has created an exclusive collection of commemorative bullion bars dedicated to Ducati's Centenary, designed for Ducati enthusiasts and collectors of unique and prestigious items.

To mark this extraordinary anniversary, the following limited-edition products have been designed and produced:

500 limited-edition 10-gram silver bullion bars;

5-gram gold bullion bars;

1-ounce gold bullion bars.

Each bullion bar features an exclusive design created specifically to commemorate Ducati's 100-year history, combining Italian manufacturing excellence with the passion for innovation, performance, and design that has always distinguished both brands.

The silver bullion bars will be available for purchase directly at the Italpreziosi stand during World Ducati Week 2026. Visitors will also have the opportunity to place exclusive pre-orders for the 5-gram and 1-ounce gold editions, securing a collector's item created to celebrate one of the most significant milestones in the history of motorcycling.

This collaboration brings together two Italian excellences united by a shared commitment to quality, attention to detail, and the ability to transform tradition into enduring value.

Through this initiative, Italpreziosi reaffirms its dedication to creating exclusive products that tell stories, celebrate remarkable achievements, and preserve emotions in precious metals for generations to come.

We look forward to welcoming you from July 3 to 5 at World Ducati Week 2026 at the Italpreziosi stand.

For more information:

Press Office LaPresse - ufficio.stampa@lapresse.it

Copyright 2026 GlobeNewswire, Inc.

After entering the Top 100, the University gains a further 11 places and enters the world's top 90 universities for the first time. Employability, global engagement, sustainability and research impact stand out

MILAN, June 18, 2026 (GLOBE NEWSWIRE) -- A new record result for Politecnico di Milano in the QS World University Rankings 2027, one of the most widely recognised academic rankings internationally. The University rises to 87th place globally, gaining 11 positions compared to the previous edition, and confirms its position as first in Italy.

After its historic entry into the Top 100 last year, the Politecnico takes a further leap forward and enters the global Top 90 for the first time, reaching its highest position ever. The result confirms constant and now structural growth: in ten years the University has gained 100 positions, moving from 187th place in 2016 to 87th in 2027.

This position places Politecnico di Milano in the top 5.8% among the 1,504 institutions included in the ranking and in the top 1% among the 8,808 universities evaluated overall by QS. There are 47 Italian universities included in the ranking.

What stands out particularly strongly is the identity of Politecnico di Milano: an international university, impact-oriented, able to train professionals that are highly sought after by the world of work and increasingly recognised for its contribution to sustainability and research.

Among the indicators showing improvement, those that stand out in particular are Employer Reputation, which measures the University's reputation among employers globally, Sustainability, International Students and Citations per Faculty, an indicator linked to the impact of scientific output. Academic Reputation also remains stable at very high levels, confirming the recognition of the Politecnico by the international academic community.

Particularly significant is the figure relating to international attractiveness. International students account for 25% of the total, compared to a global median of 8.8. A result that reflects the growing ability of Politecnico di Milano to attract talent from abroad, thanks to the quality of its education, its international reputation, its ties with the world of work and the competitiveness of the Italian university experience in the European and global landscape.

"The result of this edition is particularly significant. Alongside the improvement in consolidated indicators, from employability to global engagement, the dimension of sustainable development is also growing, a sign of Politecnico di Milano's ability to combine academic excellence and social impact. This result reflects the trust built over time and the consistency with which the University has transformed its vision into action. In fact, the ranking rewards not only performance, but the credibility of an institution", stated Rector Donatella Sciuto. "It is this credibility that has enabled us to gain one hundred positions over the last decade and that will continue to guide our path of international growth."

The QS World University Rankings 2027 evaluated 8,808 universities in 106 countries. Of these, 1,504 were included in the ranking. Politecnico di Milano confirms its position as the top Italian university for overall performance and ranks at the top nationally in several key indicators, including Employer Reputation, International Faculty, International Students, International Student Diversity, Employment Outcomes and Sustainability.

The result is also supported by the growth in scientific impact. In the period considered by QS, Politecnico di Milano recorded 29,332 scientific publications and 289,758 citations excluding self-citations, confirming the international relevance of its research output.

THE NUMBERS

Global position: 87th place in the QS World University Rankings 2027.

Annual growth: +11 positions compared to the 2026 edition, when Politecnico di Milano was in 98th place.

Position in Italy: 1st place overall.

Global top tier: top 5.8% among the universities included in the ranking; top 1% among the universities evaluated overall by QS.

Ten-year trend: +100 positions in ten years, from 187th place in 2016 to 87th in 2027.

Universities evaluated: 8,808 institutions from 106 countries.

Universities ranked: 1,504, of which 47 Italian.

Indicators of excellence:

Employer Reputation: 93.6 / 100

Sustainability: 86.2 / 100

Academic Reputation: 84.5 / 100

International Research Network: 84.2 / 100

International Faculty: 75.9 / 100

International Students: 72.9 / 100

Employment Outcomes: 66.3 / 100

Citations per Faculty: 54.2 / 100

International students: 9,117 out of 36,352 total students.

Scientific output: 29,332 scientific publications and 289,758 citations excluding self-citations in the period considered by QS.

For more information:

Press Office LaPresse - ufficio.stampa@lapresse.it

Copyright 2026 GlobeNewswire, Inc.

LONDON/HOUSTON/SINGAPORE, June 18, 2026 (GLOBE NEWSWIRE) -- The next generation of AI agents could consume between 10,000 and 40,000 times more computing power per task than today's chatbots. That pressure is pushing some of the world's largest technology companies to consider putting their data centres in space. A new report from Wood Mackenzie finds they face a significant cost problem to get there.

Global data centre power demand stands at 460 TWh in 2026, equivalent to half of Japan's total power generation. Wood Mackenzie forecasts that figure will reach 1,280 TWh by 2030 and 3,700 TWh by 2040, a 703% increase from current levels, growing at 16% per year. The United States and China together account for 78% of the global planned data centre pipeline.

On the ground, that pipeline is running into real constraints. Grid connections in the United States can take up to seven years. Gas turbine equipment faces long wait times through 2030. In dry regions, cooling systems are competing for limited water supplies. Construction costs are rising from higher labour and material costs. These bottlenecks, Wood Mackenzie concludes, are driving serious exploration of orbital data centres.

The economics are not yet close.

A hypothetical 1 GW orbital data centre would cost an estimated US$170 billion, more than three times the equivalent terrestrial facility, with launch and satellite costs accounting for approximately 60% of that total. To bring orbital costs to parity with terrestrial alternatives would require a 70% reduction. That is achievable, the report notes, only if the historical trend of exponential cost declines in space launch continues.

There is reason to think it might. Global orbital launch attempts reached 324 in 2025, a 25% increase over 2024, with commercial operators conducting 70% of those attempts. Launch costs have already fallen approximately 90% with current-generation reusable rockets compared to their expendable predecessors. A record 4,517 satellites were deployed into orbit in 2025, 58% more than the previous year, with 87% owned by private entities.

SpaceX and xAI have announced ambitious plans to put 100 GW of orbital computing capacity into space annually, a figure ten times the combined announced pipeline of every other orbital data centre developer in the world. Non-US companies account for less than 0.5 GW of total planned orbital capacity, reflecting how concentrated this emerging sector is among US-based firms. Despite the higher costs, launch activities across the top five companies are expected to begin accelerating between 2027 and 2028.

Spending on terrestrial capacity has not slowed in the meantime. Anthropic recently committed US$ 45 billion over three years to SpaceX for access to its 300 MW Colossus 1 terrestrial data centre, deploying 220,000 Nvidia GPUs. Wood Mackenzie forecasts US$ 9 trillion in cumulative capital expenditure between 2026 and 2040 to build approximately 395 GW of new terrestrial data centre capacity under its base case.

"The constraints on terrestrial data centres are genuine, and they are not going away quickly," said Robert Liew, Research Director at Wood Mackenzie. "But putting a data centre in orbit still costs at least three times as much as building one on the ground. That gap does not close without sustained and dramatic progress on launch costs. We forecast US$ 9 trillion of terrestrial data centre investment between now and 2040. That is where capital goes first. Orbital data centres are a serious long-term proposition, but right now they remain a bet on the cost curve."

Wood Mackenzie's base case energy transition outlook does not include large-scale orbital data centres. No gigawatt-scale orbital or terrestrial facility currently exists. The report concludes that terrestrial build-out will be driven by necessity, while orbital data centres remain, for now, a technology preference.

-ENDS-

For further information please contact Wood Mackenzie's media relations team:

Chris Boba

+44 7408 841129

Chris.Boba@woodmac.com 

Mark Thomton

+1 630 881 6885

Mark.thomton@woodmac.com

Hla Myat Mon

+65 8533 8860  

hla.myatmon@woodmac.com 

Angelica Juarez

angelica.juarez@woodmac.com

You have received this news release from Wood Mackenzie because of the details we hold about you. If the information we have is incorrect you can either provide your updated preferences by contacting our media relations team. If you do not wish to receive this type of email in the future, please reply with 'unsubscribe' in the subject header.  

About Wood Mackenzie:

Wood Mackenzie is the global leader in analytics, insights and proprietary data across the entire energy and natural resources landscape. For over 50 years our work has guided the decisions of the world's most influential energy producers, utilities companies, financial institutions and governments. Now, with the world's energy system more complex and interconnected than ever before, sector-specific views are no longer enough. That's why we've redefined what's possible with Intelligence Connected: the fusion of our unparalleled proprietary data with the sharpest analytical minds, all supercharged by Synoptic AI, to deliver a clear, interconnected view of the entire value chain. Our trusted team of 2,700 experts across 30 countries breaks siloes and connects industries, markets and regions across the globe to empower our customers to identify risk sooner, spot opportunity faster and make every decision with complete confidence.

For more information, visit www.woodmac.com

Chris Boba

Wood Mackenzie

+44 (0) 7408 841129 

chris.boba@woodmac.com

Copyright 2026 GlobeNewswire, Inc.

Holafly 2026 Summer Travel Trends: The Rise of Asia

A traveler explores rich cultural heritage in Asia. According to Holafly's Summer Travel Report 2026, destinations like Japan and South Korea are leading a major shift in global travel preferences, attracting tourists seeking diverse and immersive experiences.

DUBLIN, June 18, 2026 (GLOBE NEWSWIRE) -- Holafly, the global leader in travel eSIMs, today released its Summer Travel Report 2026, revealing a major shift in global travel preferences. While Spain continues to rank as the world's most popular summer destination, Asian countries are gaining significant ground, with Japan climbing to second place globally and South Korea recording the strongest rise among the top destinations compared with last year.

The findings highlight a changing tourism landscape where iconic destinations remain strong while Asian markets continue to gain ground. Spain retains the number one position, followed by Japan, the United States and South Korea. Thailand also enters the global top 10 for the first time, reinforcing Asia's growing influence on international travel decisions. Together, these movements suggest that Asia is no longer simply an emerging travel trend, but one of the key forces shaping global tourism demand.

Japan stands out as one of the top performers in this year's ranking. The country attracted interest from travelers across North America, Europe and Asia-Pacific, positioning it as one of the most widely desired destinations worldwide. Tokyo also emerged as the most-mentioned city destination in the survey, reflecting Japan's distinctive ability to blend culture, gastronomy, technology, nature and entertainment into a single journey.

The report also reveals a significant increase in international travel activity, with 46.4% of respondents planning trips abroad, compared with 37.6% last year. At the same time, more than half of travelers expect to visit multiple destinations during a single trip, reflecting the growing appeal of multi-country itineraries and longer, experience-driven journeys. Global events are accelerating this trend; according to Holafly data, 75% of travelers planning to attend the FIFA World Cup intend to visit two or more host cities, turning a single event into a broader travel experience.

According to the Japan National Tourism Organization, Japan welcomed a record number of international visitors in 2025, while South Korea continues to benefit from the global popularity of Korean culture, entertainment and cuisine. Growing interest from younger travelers, combined with increased accessibility and expanding tourism offerings, is helping reshape the global travel map.

"Spain remains one of the world's most desirable destinations, but the strongest momentum we're seeing comes from Asia," said Daniela Prado, Brand Director at Holafly. "Japan and South Korea have become truly global destinations, attracting travelers from multiple continents and inspiring a new generation of international trips. Travelers are increasingly looking for richer and more diverse experiences, and destinations across Asia are responding to that demand."

As international travel becomes more ambitious and itineraries increasingly span multiple countries, travelers are relying more heavily on digital tools throughout their journeys. From navigation and transport to reservations, payments and communication, staying online has become an essential part of the modern travel experience, regardless of destination.

Media contact: press@holafly.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8593f859-ad89-44e6-8d02-15d7e483f8b2

Copyright 2026 GlobeNewswire, Inc.

Not intended for UK and US audiences 

*Nerandomilast long-term survival modeling presented at American Thoracic Society (ATS) 2026 and European Alliance of Associations for Rheumatology (EULAR) 2026 international congresses.

*Based on the modeling, nerandomilast consistently increased median survival in both idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF).1,2

*Modeling predicts meaningful extensions in survival with nerandomilast, including a multi-year increase in median survival when used as monotherapy, and additional gains when added to standard treatment.1,2

Ingelheim, Germany - Long-term survival modeling of Boehringer Ingelheim's oral preferential PDE4B inhibitor, nerandomilast, predicts the therapy could extend survival by up to 5.4 years in adults with idiopathic pulmonary fibrosis (IPF) and up to 3.3 years in adults with progressive pulmonary fibrosis (PPF), compared with no therapy.1,2 These findings are based on data from the Phase III FIBRONEER trials and were recently presented at the ATS and EULAR 2026 international congresses.

"I expect that nerandomilast will offer a transformative survival benefit for patients with either IPF or PPF," said Toby Maher, M.D., Ph.D., Professor of Clinical Medicine, Keck School of Medicine, USC Los Angeles. "In clinical practice, we believe that slowing FVC decline is one important precursor to improving survival in people with IPF and PPF. Data from the FIBRONEER trials, plus the survival modeling, are showing us improvements that are truly meaningful, suggesting nerandomilast may have an effect on survival beyond that mediated by reducing decline in FVC."

In patients with IPF, it is estimated that nerandomilast 18 mg monotherapy could more than double median survival to 9.1 years, extending it from 3.7 years with no therapy. For those receiving standard background therapy with nintedanib, adding nerandomilast 18 mg is predicted to increase median survival from 4.6 years to 6.0 years.1  

In patients with PPF, it is predicted that nerandomilast 18 mg monotherapy could extend median survival to 7.2 years compared to 3.9 years with no therapy. When added to background nintedanib, predicted median survival is extended from 3.4 years to 4.4 years.2 

"IPF and PPF are devastating, life-threatening diseases that ruthlessly steal time from patients. Historically, burdensome side effects have forced many to abandon therapy limiting the potential for a sustained treatment effect," said Dr. Lykke Hinsch Gylvin, Chief Medical Officer and Head of Global Medicine at Boehringer Ingelheim. "Nerandomilast represents a meaningful step forward. By offering an effective and safe therapy that patients can actually tolerate, it supports sustained, long-term treatment. If patients are able to stay on therapy longer, nerandomilast may have the potential to translate its predicted survival benefit into what really matters: more precious time with family and loved ones."

In FIBRONEER-IPF and FIBRONEER-ILD nerandomilast met its primary endpoint, demonstrating slowed lung function decline compared to placebo as measured by the absolute change in Forced Vital Capacity (FVC) from baseline to week 52 in IPF and PPF, respectively. While the key secondary endpoint* was not met in either FIBRONEER-trial, in a pooled analysis of FIBRONEER-trials, a 59% nominally significant reduction in the risk of death was observed in participants treated with nerandomilast 18 mg as monotherapy compared with placebo.3

*The key secondary endpoint was time to first acute IPF/ILD exacerbation, first hospitalization for respiratory cause, or death over the duration of trial

About the survival modeling analysis 

The survival benefits were estimated using a statistical model based on data from the FIBRONEER-IPF and FIBRONEER-ILD trials. Researchers used a standard method (Weibull distribution modeling) to estimate long-term survival outcomes over a 30-year period, assuming consistent treatment effects and discontinuation rates similar to those seen during the respective trials.1,2

It is important to note that these figures represent modeled projections, not observed patient outcomes from the clinical trials. Data from the open-label extension of the FIBRONEER trials, FIBRONEER-ON, and real-world evidence will provide further evidence into the long-term effect of nerandomilast.              

About nerandomilast

JASCAYD (nerandomilast) is an oral preferential PDE4B inhibitor with antifibrotic, immunomodulatory and vascular effects approved in the US, China, the UAE, and Japan for the treatment of adults with IPF and adults with PPF.

Regulatory submissions for nerandomilast in IPF and PPF are also under review in the European Union - having received a positive CHMP opinion in May 2026 - the UK, and other countries, with additional approvals anticipated in 2026. 

Boehringer Ingelheim is also exploring the potential of nerandomilast in two rheumatic diseases: systemic sclerosis (SSc) and myositis (IIM).

About IPF and PPF

Idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) are both conditions with irreversible build-up of scar tissue in the lungs, affecting the lungs' ability to take in and transfer oxygen into the bloodstream.4,5,6 Signs and symptoms of IPF and PPF include a persistent dry cough and shortness of breath on exertion.6,7

In IPF, the root cause of pulmonary fibrosis is not known.4 The disease primarily affects people over the age of 50 and affects more men than women.8

In PPF, the scarring of the lungs may be linked to an existing condition (e.g. rheumatoid arthritis or systemic sclerosis), which causes inflammation of the lung tissue repeatedly and leads to fibrosis. PPF can also result from exposure to inhaled substances (e.g. asbestos or mold) or be due to an unknown cause (idiopathic) and worsens despite treatment of the condition.5 

Together, IPF and PPF may affect up to 9.2 million people worldwide.9,10 Approximately half of people with IPF or PPF die within 5 years of diagnosis11,12,13 ? a higher mortality rate than many cancers.14,15

Boehringer Ingelheim

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,300 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.com.

References

Pimple et al.  Predicting long-term survival benefit of nerandomilast in patients with idiopathic pulmonary fibrosis (IPF). (Poster presented at ATS 2026)

Maher et al. Predicting long-term survival benefit of nerandomilast in patients with progressive pulmonary fibrosis (PPF). (Poster presented at EULAR 2026

Oldham J et al. (Pooled analysis from the FIBRONEER IPF and FIBRONEER ILD trials- ERS 2025) 2025;392(22):2203-2214.

Upagupta C, et al. Eur Respir Rev. 2018;27:180033.

Kondoh Y, Inoue Y. Adv Ther. 2025;42(7):2988?3001.

van Cleemput, J, et al. Adv Ther. 2019;36, 298?317.

Kondoh Y, et al. Respir Investig. 2021;59(6):709-740.

Wang J, et al. MedComm (2020). 2024;5(10):e744.

Podolanczuk AJ, et al. Eur Respir J. 2023;61(4)2200957.

Cottin V, et al. Front Med (Lausanne). 2022;9:799912.　

Zheng Q et al. ERJ Open Res. 2022;8(1):00591-2021.

Cen Z, et al. Ann Med. 2024;56(1):2406439.

Nasser M, et al. Respir Res. 2021.22 :162.

Siegel RL, et al. CA Cancer J Clin. 2024;74(1):12?49.

Vancheri C, et al. Eur Respir J. 2010;35(3):496?504.

Copyright 2026 GlobeNewswire, Inc.

LONDON, June 18, 2026 (GLOBE NEWSWIRE) -- Sompo, a leading global provider of commercial and consumer property and casualty (re)insurance, has announced the appointment of Henry MacHale as Chief Underwriting Officer and Head of Strategy for its International Markets insurance business.

Sompo's International Markets comprises 22 countries across four regions: the United Kingdom (UK), Asia-Pacific (APAC), Continental Europe (including Turkey) and Brazil.

In this new role, Mr MacHale will work closely with Sompo's regional underwriting leaders and teams to help drive strong underwriting performance, set global underwriting policy, and partner closely to ensure the implementation of pricing and underwriting risk control frameworks.

In addition, he will also work with regional CEOs to develop and shape the International Markets strategy to provide further focus on organic and inorganic growth opportunities and to enhance, through collaboration, connectivity and alignment within the business, keeping the strengths of local expertise and decision-making.

Mr MacHale, who was previously Group Chief Strategy Officer at Aspen, will be based in London and report to Alessa Quane, Chief Executive Officer, International Markets.

Ms Quane said: "Henry's appointment is an important step for our International Markets business. He has a strong track record in underwriting specialty products, and brings strategic leadership and deep industry experience, which will be invaluable as we continue to strengthen underwriting performance, enhance governance and risk controls, and sharpen the focus of our strategy across regions. I am confident that Henry's leadership and direction will help us to deliver even greater connectivity, consistency, discipline and long-term success as we continue to grow our International Markets business."

About Sompo

We are Sompo, a global provider of commercial and consumer property, casualty, and specialty insurance and reinsurance. Building on the 137 years of innovation of our parent company, Sompo Holdings, Inc., Sompo employs approximately 9,500 people around the world who use their in-depth knowledge and expertise to help simplify and resolve your complex challenges. Because when you choose Sompo, you choose The Ease of Expertise.

"Sompo" refers to the brand under which Sompo International Holdings Ltd., a Bermuda-based holding company, together with its consolidated subsidiaries, operates its global property and casualty (re)insurance businesses. Sompo International Holdings Ltd. is an indirect wholly-owned subsidiary of Sompo Holdings, Inc., one of the leading property and casualty groups in the world with excellent financial strength as evidenced by ratings of A+ (Superior) from A.M. Best (XV size category) and A+ (Strong) from Standard & Poor's. Shares of Sompo Holdings, Inc. are listed on the Tokyo Stock Exchange.

To learn more please follow us on LinkedIn or visit sompo-intl.com.

Sompo Contact

Mike Jones

Global Head of Media Relations

M: +44 7765 901899

E: mijones@sompo-intl.com

*Sompo UK's insurance and reinsurance business is underwritten by Endurance Worldwide Insurance Limited and any risks located in the European Economic Area are underwritten by SI Insurance (Europe), SA. Both companies are indirect wholly owned subsidiaries of Sompo International Holdings Ltd. Please visit sompo-intl.com to view the full status disclosure.

This announcement is for information purposes only and does not constitute an offer, solicitation or recommendation in relation to any insurance or financial product. Certain statements in this release may constitute forward-looking statements, which are subject to risks and uncertainties, and actual outcomes may differ materially.

Copyright 2026 GlobeNewswire, Inc.

Perluasan strategis portofolio ekstrak botani memperkuat dukungan regional bagi pelanggan industri kecantikan, perawatan pribadi, dan farmasi

ROTTERDAM, Belanda, June 18, 2026 (GLOBE NEWSWIRE) -- Univar Solutions B.V., anak perusahaan Univar Solutions LLC ("Univar Solutions" atau "Perusahaan"), penyedia solusi global terkemuka bagi pengguna bahan baku khusus dan bahan kimia, hari ini mengumumkan perluasan kemitraan distribusi dengan American Distilling melalui divisinya yaitu Ingredients + Specialties from Univar Solutions.

Berdasarkan perjanjian baru ini, Univar Solutions akan mendistribusikan portofolio bahan baku khusus alami berkualitas tinggi dari American Distilling. Perjanjian ini mencakup witch hazel tradisional (opsi bebas alkohol dan tingkatan mutu yang dapat disesuaikan) untuk aplikasi perawatan pribadi, kosmetik, dan farmasi di sejumlah pasar terpilih di Eropa, Timur Tengah, dan Afrika (EMEA)*.

"Kemitraan dengan American Distilling di EMEA memperkuat posisi kami sebagai distributor terkemuka dan tepercaya untuk rangkaian produk ini, sekaligus memperkuat penawaran ekstrak botani kami," ujar Nick Powell, CEO Ingredients + Specialties from Univar Solutions. "Kami telah lama mendukung bahan baku khusus ini di Amerika Utara, dan dengan rantai pasok yang kuat serta tim teknis berpengalaman yang kini tersedia di kawasan ini, kami dapat menyediakan stok lokal dan pasokan yang lebih cepat bagi pelanggan."

Witch hazel adalah ekstrak botani multifungsi yang digunakan dalam produk perawatan wajah, pembersih, sabun mandi cair, perawatan rambut, gel mata, dan produk kebersihan pribadi. Berasal dari kawasan hutan di Amerika Serikat bagian Timur Laut, bahan turunan Hamamelis ini memiliki manfaat alami sebagai astringen, antiinflamasi, antioksidan, dan antimikroba. Sebagai pengganti berbasis tanaman yang lebih lembut dibandingkan astringen sintetis, bahan ini mendukung berbagai aplikasi, mulai dari toner dan pelembap hingga pad, salep, krim, semprotan, dan formulasi terapeutik, yang meningkatkan kandungan alami serta kinerja produk secara keseluruhan.

"Kemitraan ini merupakan langkah penting dalam menghadirkan produk witch hazel berkualitas tinggi berstandar United States Pharmacopeia (USP) kepada pelanggan di kawasan EMEA," kata Bryan Jackowitz, wakil presiden American Distilling, Inc. "Melalui kolaborasi dengan Univar Solutions, kami kini dapat memasarkan seluruh portofolio ekstrak witch hazel untuk kosmetik dan farmasi sehingga pelanggan memiliki fleksibilitas lebih besar dalam menentukan solusi yang paling sesuai dengan kebutuhan aplikasi spesifik mereka, yang didukung oleh infrastruktur distribusi yang kuat untuk membantu memperkuat rantai pasok mereka. Kami antusias dengan potensi jangka panjang dari kolaborasi ini dan berharap dapat tumbuh bersama."

Melalui penambahan portofolio ini, Univar Solutions semakin memperkuat posisinya sebagai distributor terkemuka untuk bahan baku berkinerja tinggi bagi berbagai merek yang mendorong perkembangan generasi baru produk kecantikan, perawatan pribadi, dan farmasi. Pelanggan mendapatkan manfaat dari Perusahaan dalam bentuk dukungan formulasi yang komprehensif, kemampuan laboratorium yang canggih, wawasan pasar yang mendalam, dan jaringan distribusi yang kuat. Perusahaan juga menyediakan akses ke Solution Center globalnya di Essen, Jerman, yang memberikan dukungan regional untuk pengembangan produk dan peningkatan skala produksi.

Pelajari lebih lanjut tentang portofolio dan kapabilitas teknis Ingredients + Specialties from Univar Solutions.

*Pasar yang tercakup dalam perjanjian ini meliputi: Albania, Aljazair, Austria, Belgia, Belanda, Bosnia, Bulgaria, Denmark, Estonia, Finlandia, Herzegovina, Hungaria, Inggris Raya, Irlandia, Italia, Jerman, Kroasia, Latvia, Lituania, Luksemburg, Makedonia, Maroko, Moldova, Monako, Norwegia, Polandia, Portugal, Prancis, Republik Ceko, Rumania, Serbia, Slowakia, Slovenia, Spanyol, Swedia, Swiss, Tunisia, Turki, Ukraina, dan Yunani.

Tentang Univar Solutions

Univar Solutions merupakan distributor global terkemuka untuk bahan kimia khusus dan bahan baku, yang mewakili portofolio premium dari para produsen terkemuka di dunia. Didukung oleh salah satu armada transportasi milik sendiri dan tim penjualan teknis terbesar di industri, keahlian teknis tentang logistik yang tak tertandingi, pengetahuan mendalam tentang pasar dan regulasi, kemampuan formulasi dan pengembangan resep, serta perangkat digital terdepan, Perusahaan memiliki posisi kuat untuk menawarkan solusi khusus dan layanan bernilai tambah untuk berbagai pasar, industri, dan aplikasi. Dalam mewujudkan tujuannya untuk membantu menjaga masyarakat tetap sehat, terpenuhi kebutuhan pangannya, bersih, dan aman, Univar Solutions berkomitmen membantu pelanggan dan pemasok berinovasi serta berfokus pada semangat Tumbuh Bersama. Pelajari lebih lanjut di univarsolutions.com.

Tentang Ingredients + Specialties from Univar Solutions

Ingredients + Specialties from Univar Solutions menghadirkan produk, tenaga ahli, dan hasil terbaik bagi pelanggan serta pemasok bahan khusus yang berupaya menunjang kehidupan modern. Dengan memadukan sains, inovasi, dan keahlian mendalam dengan portofolio bahan khusus terkemuka, kami membantu menemukan solusi yang dibutuhkan untuk secara aman meningkatkan kualitas hidup dan masyarakat di seluruh dunia. Pelajari lebih lanjut di univarsolutions.com.

Tentang American Distilling

American Distilling berkomitmen mempertahankan posisinya sebagai pemimpin industri, dengan memasok produk bahan baku Witch Hazel hasil distilasi yang berkualitas tinggi dan berkelanjutan bagi industri perawatan kesehatan, kecantikan, dan farmasi. Staf profesional mereka yang bertalenta berdedikasi untuk menghadirkan standar tertinggi dalam layanan pelanggan, integritas pribadi, dan nilai bagi konsumen. Setiap hari, mereka membuktikan keahliannya melalui produksi bahan baku dengan "kualitas unggul yang terjamin" untuk berbagai formulasi, sekaligus membantu pengembangan produk baru guna membangun kemitraan jangka panjang dengan para pelanggan berharga mereka. Pelajari lebih lanjut di americandistilling.com.

Pernyataan dan Informasi Berwawasan ke Depan

Komunikasi ini memuat "pernyataan berwawasan ke depan" berdasarkan hukum yang berlaku tentang aspek keuangan dan operasional yang terkait dengan bisnis Perusahaan. Pernyataan berwawasan ke depan umumnya dapat dikenali dari penggunaan kata-kata seperti "meyakini," "memperkirakan," "mungkin," "akan," "seharusnya," "dapat," "berupaya," "bermaksud," "berencana," "mengestimasi," "mengantisipasi," atau istilah sebanding lainnya. Seluruh pernyataan berwawasan depan yang disampaikan dalam komunikasi ini dibatasi oleh pernyataan kehati-hatian ini.

Pernyataan berwawasan ke depan mengandung berbagai risiko dan ketidakpastian yang diketahui maupun tidak diketahui, yang sebagian besar mungkin berada di luar kendali Perusahaan, yang dapat menyebabkan ekspektasi tidak tercapai atau dapat berdampak secara signifikan dan merugikan terhadap bisnis, kondisi keuangan, hasil operasi, atau arus kas Perusahaan. Meskipun pernyataan berwawasan ke depan didasarkan pada asumsi yang dianggap wajar oleh manajemen, kami mengingatkan bahwa informasi berwawasan ke depan yang disajikan dalam komunikasi ini bukan merupakan jaminan atas peristiwa atau hasil di masa mendatang, dan bahwa peristiwa atau hasil aktual dapat berbeda secara signifikan dari hal-hal yang dinyatakan secara tersurat maupun tersirat oleh informasi berwawasan ke depan yang dimuat dalam komunikasi ini. Untuk informasi tambahan mengenai faktor-faktor yang dapat memengaruhi Perusahaan, silakan lihat laporan tahunan terbaru Perusahaan dan laporan keuangan lainnya, termasuk informasi yang tercantum dalam bagian berjudul "Faktor Risiko." Setiap pernyataan berwawasan ke depan hanya mencerminkan pandangan Perusahaan pada tanggal komunikasi ini dan tidak boleh dianggap sebagai menggambarkan pandangan Perusahaan pada tanggal setelahnya dan Perusahaan tidak berkewajiban untuk memperbarui pernyataan berwawasan ke depan apa pun, kecuali sebagaimana diwajibkan oleh hukum.

Media Relations

Dwayne Roark

+1 331-777-6031

mediarelations@univarsolutions.com

Copyright 2026 GlobeNewswire, Inc.

The MICHELIN Guide Slovenia 2026 features 74 restaurants, two more than last year. Slovenia now boasts a total of 13 MICHELIN stars, one more than in 2025.

LJUBLJANA, Slovenia, June 18, 2026 (GLOBE NEWSWIRE) -- Hisa Franko, led by Ana Ros, has retained the highest distinction of three MICHELIN stars, while Milka Restaurant, under the leadership of David Zefran, has once again been awarded two MICHELIN stars.

Eight restaurants received one MICHELIN star, with Galerija okusov joining the category for the first time this year. The Bib Gourmand distinction was awarded to 12 restaurants. The Selected category includes 52 restaurants, six of them new.

This year also marked the debut of the MICHELIN Opening of the Year Award in Slovenia. Additional special recognitions included the Young Chef Award, presented to Marko Magajne of Galerija okusov; the Sommelier Award, presented to Nejc Farčnik of Gric; and the Service Award, awarded to Peter Patajc of Gostilnica Ruj. The Opening of the Year Award went to Gostilna Francl, led by Sebastijan Kovacic.

MSc Maja Pak Olaj, Director of the Slovenian Tourist Board, emphasised: "This year's MICHELIN Guide Slovenia results once again confirm that Slovenia is strengthening its position as one of Europe's most recognisable gastronomic destinations. The inclusion of 74 restaurants from across the country demonstrates that top-quality gastronomy is becoming an increasingly important part of Slovenia's tourism offer and a key driver of higher value-added tourism development.

Our partnership with MICHELIN contributes to Slovenia's international visibility, raises quality standards, and strengthens the reputation of Slovenian chefs and restaurants. We are especially pleased that Slovenia received the Opening of the Year Award for the first time this year, alongside the Young Chef, Sommelier, and Service Awards, all of which highlight excellence across different areas of gastronomy. In terms of MICHELIN-recognised restaurants per capita, Slovenia ranks around the European average among countries included in the guide, confirming the remarkable quality and ambition of Slovenian gastronomy. Congratulations to all recipients. The Slovenian Tourist Board will continue to support the development and international promotion of Slovenia as a destination of outstanding gastronomic experiences."

Read the press release

MICHELIN Guide marks seven years in Slovenia

More information is available as well as on the Taste Slovenia and Slovenia.info portals. Photos and video statements from the awards ceremony are available here.

press@slovenia.info

Copyright 2026 GlobeNewswire, Inc.

WUHU, China, June 17, 2026 (GLOBE NEWSWIRE) -- Chery Group's FREELANDER 8 was showcased at the Abu Dhabi Investment Forum held at The Peninsula Shanghai, demonstrating a benchmark of premium quality for global markets, backed by a globally integrated R&D, manufacturing and quality control system.

The forum brought together government representatives, business leaders, investors and international partners, providing an important platform for FREELANDER to engage with key stakeholders ahead of its upcoming Middle East brand launch.

As the first strategic model under of the brand, FREELANDER 8 has been developed in accordance with mainstream international safety requirements and is engineered to meet the standards of five major global safety assessment programs: Euro NCAP, C-NCAP, ANCAP, Latin NCAP and ASEAN NCAP. From body structure development to comprehensive active and passive safety technologies, the vehicle has been designed to deliver a high level of protection for drivers and passengers across diverse driving environments.

Beyond safety and quality, FREELANDER 8 integrates advanced intelligent technologies developed for global users. An intelligent cockpit powered by the Qualcomm Snapdragon 8295P chip provides seamless connectivity, intelligent interaction and enhanced digital experiences, while SIP (Super Intelligent Parking) offered in selected markets, extends the vehicle's intelligent mobility experience through remote parking and vehicle summon functions. Together, these technologies contribute to FREELANDER's Smart Confidence experience while enhancing convenience in everyday driving scenarios.

Whether delivering confident all-terrain capability across challenging road conditions or intelligent experiences for everyday mobility, quality remains the foundation of FREELANDER 8's competitiveness in global markets. Backed by a comprehensive global quality assurance system, the vehicle has undergone extensive validation, regulatory compliance testing and scenario-based assessments across multiple regions with more than 1,000 test vehicles deployed worldwide, helping ensure adaptability to different climates, road conditions and customer expectations.

FREELANDER 8 will be manufactured at FREELANDER Super Factory at the Chery Jaguar Land Rover Intelligent Manufacturing Base in Changshu ? a globally advanced manufacturing base with total investment exceeding USD 1.5 billion and an additional USD 440 million invested in smart manufacturing upgrades dedicated for FREELANDER.

As Jaguar Land Rover's first full-vehicle manufacturing facility outside the UK, the plant operates under globally aligned quality standards and advanced manufacturing processes. From body structure development and precision assembly to final quality inspection, FREELANDER 8 benefits from a manufacturing ecosystem designed to deliver consistent quality, reliability and long-term durability for customers worldwide.

Its appearance at the Abu Dhabi Investment Forum not only demonstrates the strength of FREELANDER's global development, manufacturing and quality ecosystem, but also reflects the achievements of a long-term partnership and an innovative collaborative model that supports international growth and shared value creation. As preparations continue for the brand's upcoming Middle East launch, FREELANDER 8 demonstrates how British Craftsmanship, Smart Confidence and All-Terrain Freedom are being brought together through a globally integrated safety and quality system.

Vincent CHEN

freelander.international@mychery.com

Copyright 2026 GlobeNewswire, Inc.